H — Medical ResearchEIN: 460886344· Ruling Year: 2014

Transcelerate Biopharma Inc

West Conshohocken, Pennsylvania

BHealth Score
58B

Financial Health Score

9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.

Above Average

How This Organization Compares

Compared to 5 peers in Medical Research with $10M-$100M revenue

Working Capital Ratio (net assets ÷ expenses)

This Org0.36×
Peer Median3.10×
💰
$34.2M
Total Revenue
📊
$32.5M
Total Expenses
🏦
$11.6M
Net Assets
📋
$36.5M
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+1.7%
Year-over-year change (2022 → 2023)
Net Margin
+4.8%
Revenue minus expenses as % of revenue
Working Capital Ratio
0.36
Net assets divided by total expenses
Liabilities-to-Assets
75.9%
Total liabilities as % of total assets

Filing History

12 filings on record
YearRevenueExpensesAssets
2023$34,168,812↑2%$32,521,149↓5%$48,107,662↓1%
2022$33,600,302↑8%$34,262,372↑3%$48,482,660↓4%
2021$31,090,660↓3%$33,180,341↑18%$50,373,384↑2%
2020$31,974,894↑14%$28,107,965↑5%$49,374,410↑8%
2019$27,979,345↑11%$26,700,072↓14%$45,613,199↑18%
2018$25,318,445↓3%$30,891,037↑6%$38,632,750↓12%
2017$26,172,580↑27%$29,275,313↑23%$43,979,845↓2%
2016$20,679,184↓19%$23,733,704↑46%$44,721,813↑3%
2015$25,465,264↑67%$16,269,496↑38%$43,370,074↑24%
2014$15,293,388↑12%$11,780,323↑73%$34,898,547↑285%
2013$13,643,765↑141%$6,823,303↑24%$9,075,300↑55%
2012$5,672,849$5,494,217$5,857,436

Frequently Asked Questions

What does Transcelerate Biopharma Inc do?▼

Transcelerate Biopharma Inc is a medical research nonprofit organization based in Pennsylvania. It is classified under NTEE code H99 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Transcelerate Biopharma Inc financially healthy?▼

Based on our 9-metric Financial Health Score model, Transcelerate Biopharma Inc has a score of 58/100 (Grade: B). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.

How much revenue does Transcelerate Biopharma Inc generate?▼

Transcelerate Biopharma Inc reports $34.2M in annual revenue and holds $55.1M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in Pennsylvania.